ValiScreen Human Adenosine A3 Cell Line

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Australia

Austria

Belgium

Brazil *

Canada

China *

Denmark

Finland

France

Germany

Hong Kong *

India *

Ireland

Italy

Japan *

Luxembourg

Mexico *

Netherlands

Norway

Philippines *

Republic of Korea *

Singapore *

Spain

Sweden

Switzerland

Thailand *

United Kingdom

United States

ValiScreen Human Adenosine A₃ Cell Line

TDS

Stable, recombinant ValiScreen® cell line expressing the Adenosine A₃ receptor, human recombinant in CHO-K1 host cells.

For research use only. Not for use in diagnostic procedures. Cell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use. Click here.

View product information

Feature	Specification
Application	cAMP Drug Discovery & Development
Special Ordering Information	Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
Validation	Binding cAMP GTPγS

Stable, recombinant ValiScreen® cell line expressing the Adenosine A₃ receptor, human recombinant in CHO-K1 host cells.

View product information

Product Variant

Unit Size: 5 million cells

Part #:

ES-012-C

Request More Information

Product information

Overview

Revvity's ValiScreen cell lines are provided in two vials of frozen cells, each containing ~2.5 x 10⁶ cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available each cell line.

Clonal selection Revvity's ValiScreen cell lines is carried out with receptor binding. High and low expressors are n tested and selected optimal binding and functional response according to receptor specific transduction pathway.

Revvity’s ValiScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Please use link above to accept Terms and Conditions or to request an agreement for commercial use.

Specifications

Other Specifications

Application	cAMP Drug Discovery & Development
Brand	ValiScreen
G-Alpha Natural Receptor	Gi/Go
Host Cell Line	CHO-K1
Host Species	Human
One Unit Contains	2.0 Vials
Product Group	Cell Line
Receptor	Adenosine
Second Messenger Release	cAMP GTP exchange
Shipping Conditions	Shipped in Dry Ice
Special Ordering Information	Requires accepted Terms and Conditions. Additional agreement needed for commercial use.
Target Class	GPCR
Therapeutic Area	Cardiovascular Central Nervous System Inflammation Metabolic
Unit Size	5 million cells
Validation	Binding cAMP GTPγS